Premium
Mechanisms underlying the inhibition of the cytochrome P450 system by copper ions
Author(s) -
Letelier M. E.,
Faúndez M.,
JaraSandoval J.,
MolinaBerríos A.,
CortésTroncoso J.,
AracenaParks P.,
MarínCatalán R.
Publication year - 2009
Publication title -
journal of applied toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.784
H-Index - 87
eISSN - 1099-1263
pISSN - 0260-437X
DOI - 10.1002/jat.1460
Subject(s) - monooxygenase , chemistry , cytochrome p450 , microsome , cytochrome , biochemistry , enzyme , stereochemistry
Copper toxicity has been associated to the capacity of free copper ions to catalyze the production of superoxide anion and hydroxyl radical, reactive species that modify the structure and/or function of biomolecules. In addition, nonspecific Cu 2+ ‐binding to thiol enzymes, which modifies their catalytic activities, has been reported. Cytochrome P450 (CYP450) monooxygenase is a thiol protein that binds substrates in the first and limiting step of CYP450 system catalytic cycle, necessary for the metabolism of lipophilic xenobiotics. Therefore, copper ions have the potential to oxidize and bind to cysteinyl residues of this monooxygenase, altering the CYP450 system activity. To test this postulate, we studied the effect of Cu 2+ alone and Cu 2+ /ascorbate in rat liver microsomes, to independently evaluate its nonspecific binding and its pro‐oxidant effects, respectively. We assessed these effects on the absorbance spectrum of the monooxygenase, as a measure of structural damage, and p ‐nitroanisole O ‐demethylating activity of CYP450 system, as a marker of functional impairment. Data obtained indicate that Cu 2+ could both oxidize and bind to some amino acid residues of the CYP450 monooxygenase but not to its heme group. The differences observed between the effects of Cu 2+ and Cu 2+ /ascorbate show that both mechanisms are involved in the catalytic activity inhibition of CYP450 system by copper ions. The significance of these findings on the pharmacokinetics and pharmacodynamics of drugs is discussed. Copyright © 2009 John Wiley & Sons, Ltd.